MAYO, T.; ARMSTRONG, A. W.; KIRCIK, L.; SILVERBERG, J.; BLAUVELT, A.; ESDALIE, B.; SCHNEIDER, S.; MARK, T.; GOODERHAM, M.; ALEXIS, A. F. Efficacy and safety of up to two years of tralokinumab treatment in adults of different racial subgroups with moderate-to-severe atopic dermatitis. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 6, n. 6, p. s74, 2022. DOI: 10.25251/skin.6.supp.74. Disponível em: https://jofskin.org/33014/index.php/skin/article/view/1831. Acesso em: 3 jul. 2024.